2'-Deoxycytidine
2'-Deoxycytidine
2'-Deoxycytidine
Thermo Scientific Chemicals

2'-Deoxycytidine

CAS: 951-77-9 | C9H13N3O4 | 227.22 g/mol
Have Questions?
更改视图buttonViewtableView
数量:
5 g
25 g
货号 J63062.14
又称 J63062-14
价格(CNY)
-
数量:
25 g
请求批量或定制报价
化学标识符
CAS951-77-9
IUPAC Name4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one
Molecular FormulaC9H13N3O4
InChI KeyCKTSBUTUHBMZGZ-JORGKRSHNA-N
SMILESNC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1
查看更多内容
规格Specification Sheet规格表
Appearance (Color)White to off-white
FormPowder
Assay (HPLC)97.0% min
2?-Deoxycytidine (deoxyC) is one of the deoxynucleosides which after phosphorylation to dCTP is used to synthesis DNA via various DNA polymerases or reverse transcriptases. 2?-Deoxycytidine (deoxyC) is the substrate for deoxycytidine deaminase (EC 3.5.4.14) which converts it into 2?-deoxyuridine. 2?-Deoxycytidine is phosphorylated to the nucleotide dCMP by the enzyme deoxycytidine kinase (DCK).

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
2′-Deoxycytidine (deoxyC) is one of the deoxynucleosides which after phosphorylation to dCTP is used to synthesis DNA via various DNA polymerases or reverse transcriptases. 2′-Deoxycytidine (deoxyC) is the substrate for deoxycytidine deaminase (EC 3.5.4.14) which converts it into 2′-deoxyuridine. 2′-Deoxycytidine is phosphorylated to the nucleotide dCMP by the enzyme deoxycytidine kinase (DCK).

Solubility
Soluble in water, DMSO.

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Keep away from strong oxidizing agents. Stable under recommended storage conditions.
RUO – Research Use Only

General References:

  1. JK Christman. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 200221 (35), 5483-5495.
  2. LW Herte.; GB Boder.; JS Kroin.; SM Rinzel, GA Poore. Evaluation of the antitumor activity of gemcitabine (2', 2'-difluoro-2'-deoxycytidine). Cancer research. 199050 (1), 4417-4419.